Over $3,000 Paid Clinical Trials
440 studies
Extended inpatient Phase 1 studies with longer residential stays or multiple periods may compensate $3,000 or more.
Compensation amounts shown are typical ranges for this study type — not guaranteed amounts. Actual compensation is set by each study sponsor and documented in the informed consent form. ClinicalTrials.gov does not include a structured compensation field.
Showing 241–260 of 440 studies
Recruiting
Phase 1
Study of the Safety, Tolerability, Pharmacokinetics of VV261 Tablets in Chinese Healthy Volunteers
Healthy Volunteers
Vigonvita Life Sciences58 enrolled1 locationNCT07302269
Recruiting
Phase 1
A Study to Explore the Effect of SP-624 on Brain Network Analytics in Healthy Adults and Adults With Major Depression
DepressionHealthyMajor Depressive Disorder
Sirtsei Pharmaceuticals, Inc.36 enrolled2 locationsNCT06570369
Recruiting
Phase 1
A Study of V118E in Healthy Participants (V118E-003)
Healthy
Merck Sharp & Dohme LLC126 enrolled4 locationsNCT07168915
Recruiting
Phase 1
First-in-human Study of Orally Administered KT-579 in Healthy Adult Participants
Healthy Participants
Kymera Therapeutics, Inc.96 enrolled1 locationNCT07412288
Recruiting
Phase 1
Pharmacokinetic Comparison of Vonafexor Acid and Its Lysine Salt and Evaluation of Potential Drug-Drug Interactions
Healthy Adult Male and Female Volunteers
Enyo Pharma40 enrolled1 locationNCT07251153
Recruiting
Phase 1
A Study to Learn How the Study Medicine Called PF-08653944 is Taken up Into the Blood in Adults With Overweight or Obesity.
ObesityHealthyOverweight
Pfizer54 enrolled1 locationNCT07400679
Recruiting
Phase 1
A Single- and Multiple-Ascending Dose Study of SRK-439 in Healthy Adults
Healthy
Scholar Rock, Inc.76 enrolled1 locationNCT07444294
Recruiting
Phase 1
A Study of ORX489 in Healthy Adult Participants, Aged 18 to 60 Years
Healthy Adult Male and Female Volunteers
Centessa Pharmaceuticals (UK) Limited212 enrolled1 locationNCT07413666
Recruiting
Phase 1
A First-in-Human Single and Multiple Ascending Dose Study of MT-251
Healthy Volunteers
Mirador Therapeutics, Inc.70 enrolled1 locationNCT07423299
Recruiting
Phase 1
A Study to Compare Blood Levels of Different Dosage Formulations of the Study Medicine That Is a CGRP Receptor Antagonist in Healthy Adults
Healthy Volunteer
Pfizer64 enrolled1 locationNCT07261371
Recruiting
Phase 1
A Phase 1 Study of CLYM116 in Normal Healthy Volunteers
Healthy Volunteers
Climb Bio, Inc.48 enrolled1 locationNCT07248865
Recruiting
Phase 1
A Study to Evaluate the Effects of CYP2D6 Phenotypes on the Pharmacokinetics of Xanomeline Following KarXT Administration in Healthy Adult Participants
Healthy Volunteers
Karuna Therapeutics, Inc., a Bristol Myers Squibb company56 enrolled3 locationsNCT07204418
Recruiting
Phase 1
Alternation in the Human Microbiome With Commonly Used Topical Medications
Healthy
University of California, Davis24 enrolled1 locationNCT03437005
Recruiting
Phase 1
Phase 1a Single Ascending Dose Study of MIB-725 in Healthy Adults
Healthy Adults
Metro International Biotech, LLC32 enrolled1 locationNCT06815991
Recruiting
Phase 1
Safety and Efficacy of Injectable Klotho Plasmid Gene Therapy in Humans
Healthy Adults
Minicircle24 enrolled2 locationsNCT07216781
Recruiting
Phase 1
Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers
Healthy VolunteerHIV Prevention
Johns Hopkins University24 enrolled1 locationNCT07349758
Recruiting
Phase 1
A Research Study Looking at the Safety of Single and Multiple Doses of ZP9830 and How it Works in the Body of Healthy Participants
Healthy Volunteers
Zealand Pharma124 enrolled1 locationNCT06682975
Recruiting
Phase 1
Evaluate the Safety, Tolerability, PK, and PD of JMT206 Injection in Healthy Participants
Healthy Participants
Shanghai JMT-Bio Inc.44 enrolled1 locationNCT07419698
Recruiting
Phase 1
A Multiple Ascending Dose Study Evaluating the Safety and Tolerability of a Novel Formulation of QRL-101 in Healthy Participants
Healthy Participant Study
QurAlis Corporation48 enrolled1 locationNCT07421778
Recruiting
Phase 1
A Study of ABBV-295 Subcutaneous Injections to Assess Pharmacokinetics and Adverse Events in Healthy Adult Women Participants With Overweight or Obesity Taking Oral Contraceptives
Healthy Volunteer
AbbVie20 enrolled1 locationNCT07414784